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Abstract
Background: Experimental studies demonstrate that infection with trypanosoma cruzi causes
vasculitis. The inflammatory lesion process could hypothetically lead to decreased distensibility of
large and small arteries in advanced Chagas' disease. We tested this hypothesis.
Methods and results: We evaluated carotid-femoral pulse-wave velocity (PWV) in 53 Chagas'
disease patients compared with 31 healthy volunteers (control group). The 53 patients were
classified into 3 groups: 1) 16 with indeterminate form of Chagas' disease; 2) 18 with Chagas'
disease, electrocardiographic abnormalities, and normal systolic function; 3) 19 with Chagas'
disease, systolic dysfunction, and mild-to-moderate congestive heart failure. No difference was
noted between the 4 groups regarding carotid-femoral PWV (8.4 ± 1.1 vs 8.2 ± 1.5 vs 8.2 ± 1.4 vs
8.7 ± 1.6 m/s, P = 0.6) or pulse pressure (39.5 ± 7.6 vs 39.3 ± 8.1 vs 39.5 ± 7.4 vs 39.7 ± 6.9 mm
Hg, P = 0.9). A positive, significant, similar correlation occurred between PWV and age in patients
with Chagas' disease (r = 0.42, P = 0.002), in controls (r = 0.48, P = 0.006), and also between PWV
and systolic blood pressure in both groups (patients with Chagas' disease, r = 0.38, P = 0.005;
healthy subjects, r = 0.36, P = 0.043).
Conclusion: Carotid femoral pulse-wave velocity is not modified in patients with Chagas' disease,
suggesting that elastic properties of large arteries are not affected in this disorder.
The elastic properties of the large arteries are important
determinants of circulatory physiology [1]. Such proper-
ties can be assessed noninvasively by pulse-wave analysis,
by ultrasound techniques, or by calculating the velocity of
pulse-wave transit in a given arterial segment. The meas-
urement of pulse-wave velocity (PWV) by noninvasive
devices has been considered an index of arterial distensi-
bility and stiffness. Indeed, using a modification of the
Bramwell-Hill equation [2], it can be considered that dis-
tensibility is equal to the inverse of blood viscosity multi-
plied by the square of PWV. So, the carotid-femoral PWV
is a recognized index of aortic distensibility and stiffness
and has been shown to be an important predictor of car-
diovascular events in many disorders, such as end-stage
renal disease, arterial hypertension, diabetes, and
ischemic heart disease [3-5].
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Chagas' disease, or South American trypanosomiasis, is
caused by the hemoflagellate Trypanosoma cruzi and is an
important cause of heart disease in South and Central
America. Patients with Chagas' disease have an early
impairment of baroreflex function [6-8]. A possible mech-
anism responsible, at least in part, for this abnormality
could be an impairment in arterial distensibility. Data
obtained in experimental studies support this issue by
demonstrating that acute infection by trypanosoma cruzi
causes inflammatory lesions in large arteries, affecting
both muscular and endothelial layers, besides an
increased production of alpha tumoral necrosis factor and
interleukin [9,10]. Although such alterations could hypo-
thetically lead to a decreased distensibility of the large
arteries in the chronic stage of Chagas' disease, this
hypothesis has never previously been tested. Therefore,
we sought to assess carotid-femoral PWV, a well-recog-
nized index of aortic distensibility, in patients with differ-
ent forms of Chagas' disease and to determine the clinical,
echocardiographic, and functional parameters correlated
with PWV in such patients.
Methods
Population
From July 1999 to August 2000, 53 patients with Chagas'
disease (20 men and 33 women, mean age 49 ± 8.6 years)
and 31 healthy volunteers (15 men and 16 women, mean
age 45.3 ± 8.9 years) were studied. The diagnosis of Cha-
gas' disease was based on positive serological reactions to
Chagas' disease assessed by 2 methods, ELISA and
immunofluorescence. On the basis of medical history,
physical examination, roentgenogram of the thorax and
electrocardiogram, all subjects were free of other cardio-
vascular or systemic disease. All subjects showed normal
laboratory testing including a complete blood account,
serum electrolytes, blood glucose, blood urea nitrogen,
serum creatinine, total cholesterol, and triglyceride levels.
A roentgenogram of the thorax was performed in all indi-
viduals. All patients with Chagas' disease underwent bidi-
mensional echocardiography (Phillips System-ATL HDI
3000, 2–4 MHz transducer, Phillips, Bothell, WA) to
assess systolic function. Patients with a left ventricle (LV)
fractional shortening ≤25% were considered as having
systolic dysfunction. In addition, we also evaluated the
peak Vo2 (maximal oxygen consumption) and slope Ve/
Vco2 values during a maximal treadmill test in 50 patients
with Chagas' disease. Pulmonary ventilation and gas-
exchange data were determined on a breath-by-breath
basis with a computerized system (Model Vmax 229, Sen-
sormedics, Yorbalinda, CA). The peak oxygen uptake was
considered to occur at the end of the bicycle cardiopulmo-
nary exercise test (ramp protocol with a 10- to 15-W incre-
ment every minute up to exhaustion), when the subject
no longer maintained the bicycle velocity at 60 rpm.
The exclusion criteria were a prior history of systemic
hypertension or current blood pressure ≥ 140 × 90 mm
Hg, age above 65 years, history of diabetes mellitus or
serum glucose above 126 mg/dL, total cholesterol above
240 mg/dL, serum creatinine above 1.4 mg/dL, chronic
atrial fibrillation, concomitant severe chronic disease, and
patients with functional class IV (NYHA) heart failure. The
patients were classified into 3 groups: a) group 1 – 16
patients with an indeterminate form of Chagas' disease,
characterized by positive serum Machado Guerreiro reac-
tion and no clinical manifestations; b) group 2 – 18
patients with Chagas' disease, electrocardiographic abnor-
malities, and normal LV systolic function; c) group 3 – 19
patients with Chagas' disease, systolic dysfunction, and
congestive heart failure (CHF). The clinical data and PWV
measurements obtained from the 3 groups of patients
were compared with those obtained in 31 healthy age-sex
matched volunteers with no cardiovascular disease (group
4, control group). Among the patients with CHF (group
3), 4 were in NYHA functional class I, 12 were in class II,
and 3 were in class III. Seven patients in this group were
on digoxin, 7 were on furosemide, 11 were on hydrochlo-
rothiazide, 15 were on an angiotensin-converting-enzyme
(ACE) inhibitor, 5 were on spironolactone. No patient
was on beta-blocker therapy. For ethical reasons, we
decided not to withdraw the medications. However, to
minimize the effects of ACE inhibitors and diuretics on
arterial distensibility, patients were asked not to take the
morning doses of such drugs on the day of diagnostic test-
ing. Written informed consent was obtained from all sub-
jects before the study, and the protocol was approved by
the Medical Ethics Committee of the University of São
Paulo, Medical School, São Paulo, Brazil.
Carotid-femoral PWV measurements and blood pressure 
determination
The measurements were performed with the patient in the
supine position. Brachial blood pressure was measured
with a mercury sphygmomanometer after 15 minutes of
rest. Phases I and V of the Korotkoff sounds were consid-
ered respectively as systolic and diastolic blood pressure.
Two measurements 5 minutes apart were averaged. Pulse
pressure was calculated as the difference between systolic
and diastolic blood pressure.
After blood pressure determination, the PWV measure-
ment was performed in a controlled environment at
22°C. We measured carotid-femoral PWV by using an
automatic device, Complier (Colson, Garges les Gonesses,
France), which allows on-line pulse-wave recording and
automatic calculation of PWV with 2 transducers (TY 306,
Fukuda, Tokyo, Japan), one positioned at the base of the
neck for the common carotid artery and the other over the
femoral artery. The PWV is automatically calculated as the
distance between these points divided by the time theJournal of Negative Results in BioMedicine 2006, 5:9 http://www.jnrbm.com/content/5/1/9
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pulse wave takes to go from one point to another. At least
10 measurements were taken in each subject, and the
average was used for the analysis. The validation of this
automatic method and its reproducibility has been previ-
ously described [11].
The correlations between carotid-femoral PWV and the
following parameters were also evaluated: age, systolic
blood pressure, serum sodium, LV fractional shortening,
LV end systolic and diastolic diameters, and peak VO2.
Statistical analysis
Data are expressed as mean ± SD. The Student t test was
used to compare normally distributed continuous varia-
bles. Chi-square (χ2) test was used to compare categorical
baseline characteristics. Analysis of variance (ANOVA)
was used for the comparison between the 3 groups of
patients and the control group. Linear regression analysis
(Pearson's analysis) was used to assess correlations of con-
tinuous variables.
The reproducibility of PWV measurements by the device
used in our study has been described [11], and the accu-
racy is better if a consistent number of measurements are
done. In our study, each patient had at least 10 measure-
ments, and a mean value of these measurements was
obtained only if the standard deviation was below 0.5 m/
s. Based on other studies, the estimated number of sub-
jects in each group to give a statistically significant power
in the differences of PWV was at least 15 (all groups of our
study had more than 15 subjects). A clinically significant
difference between 2 PWV measurements is probably
above 1 m/s. P < 0.05 was considered significant. All data
were processed with SPSS System software.
Results
Baseline characteristics
Baseline demographic, clinical, laboratory, and echocar-
diographic parameters of the 4 groups are shown in the
table 1. No difference was observed between the groups
regarding demographic, clinical, and laboratory tests.
Likewise, no difference was observed between the 4
groups regarding pulse pressure. Thus, the mean values of
group 1 were 39.5 ± 7.6 mm Hg, group 2 were 39.3 ± 8.1
mm Hg, group 3 were 39.5 ± 7.4 mm Hg, and control
group were 39.7 ± 6.9 mm Hg (P = 0.99). All echocardio-
graphic measurements were significantly different and
obviously impaired in group 3 that comprised patients
with systolic dysfunction. Also, the peak VO2 was signifi-
cantly decreased in group 3 patients with systolic dysfunc-
tion, in comparison with that in patients without heart
failure.
PWV analysis
Carotid-femoral PWV values for the 4 groups of subjects
are shown in figure 1. No difference was observed
between the groups (P = 0.57). We also did ANOVA anal-
ysis by adjusting PWV values by age and mean blood pres-
Table 1: Baseline characteristics in control and Chagas' disease groups.
Variables Group 1 N = 16 Group 2 n = 18 Group 3 n = 19 Control n = 31 P value
Age (years) 49.7 ± 5.9 47.4 ± 9.3 49 ± 10 45.3 ± 8.9 0.33
Male sex 6 (37.5 %) 6 (33.3 %) 8 (42 %) 15 (48.4 %) 0.30
Systolic blood pressure (mm 
Hg)
120.5 ± 6.8 118.9 ± 11.3 116.6 ± 11.3 118.1 ± 10.3 0.72
Diastolic blood pressure (mm 
Hg)
79.8 ± 2.9 80 ± 5 77.6 ± 5.8 76.7 ± 7 0.29
Heart rate (bpm) 74.6 ± 5.7 67.7 ± 7.6 74 ± 12 71.8 ± 10 0.13
Body mass index (Kg/m2) 25.8 ± 4.3 24.4 ± 3.3 23.4 ± 4.5 25.4 ± 3.7 0.26
Total cholesterol (mmol/L) 208 ± 20.8 197 ± 21 190 ± 34 196.3 ± 17.8 0.28
HDL (mmol/L) 46.4 ± 8.4 48.4 ± 9.8 46.8 ± 15.4 50.3 ± 9.8 0.75
LDL (mmol/L) 139 ± 20.3 130.4 ± 15.4 131.7 ± 27.6 130.8 ± 16 0.68
Triglycerides (mmol/L) 131.4 ± 59.6 117.1 ± 49.8 128 ± 4 128.5 ± 49.2 0.89
Hematocrit 41.2 ± 4 42 ± 3 40 ± 3 39.8 ± 2.9 0.20
Hemoglobin (g/dl) 14.4 ± 1.2 14.5 ± 0.7 14 ± 1.2 14 ± 0.8 0.37
Serum glucose (g/dL) 98 ± 9.5 93.3 ± 6.4 101 ± 12.7 93.4 ± 9.3 0.12
Serum sodium (mEq/L) 140 ± 1.6 139.7 ± 1.6 139.3 ± 2.6 139.7 ± 2 0.75
Blood urea nitrogen (mg/dL) 32.8 ± 5.3 33.8 ± 5 38.8 ± 13.6 32.7 ± 4.6 0.20
Serum creatinine (mg/dL) 0.95 ± 0.1 0.97 ± 0.2 1.05 ± 0.2 0.96 ± 0.1 0.25
End diastolic diameter (cm) 4.7 ± 0.43 4.87 ± 0.44 6.36 ± 1.09 _ < 0.00001
End systolic diameter (cm) 3.18 ± 0.39 3.18 ± 0.4 5.11 ± 1.2 _ < 0.00001
Ejection fraction 69.6 ± 5.2 70.3 ± 6.3 48.7 ± 11 _ < 0.00001
Fractional shortening 33 ± 3.9 33.7 ± 5 20.9 ± 6.7 _ < 0.00001
VO2 (ml/Kg/min) 20 ± 4.3 21.7 ± 7.3 14.9 ± 2.1 _ 0.003
VO2 = peak oxygen consumption.Journal of Negative Results in BioMedicine 2006, 5:9 http://www.jnrbm.com/content/5/1/9
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sure, and the differences between the 4 groups remained
statistically nonsignificant. Mean values were respectively
8.4 ± 1.1 m/s in group 1 (range 6.7 to 11), 8.2 ± 1.5 m/s
in group 2 (range 5.8 to 11.2), 8.2 ± 1.4 m/s in group 3
(range 5.9 to 11.9), and 8.7 ± 1.6 m/s in control group
(range 5.7 to 14.3).
Relationship between PWV and other variables
Among the patients with Chagas' disease, no relationship
was observed between carotid-femoral PWV and serum
sodium (r = 0.172, P = 0.21), LV fractional shortening (r =
-0.017, P = 0.90), LV end diastolic diameter (r = -0.16, P =
0.20), LV end systolic diameter (r = -0.12, P = 0.18), and
peak VO2 (r = -0.059, P = 0.68). In both the control group
(31 subjects) and the group of 53 patients with Chagas'
disease, a positive, significant, and similar correlation was
observed between carotid-femoral PWV and age (r = 0.42,
P = 0.002, Chagas' disease group; and r = 0.48, P = 0.006,
healthy subjects). Also we observed a significant correla-
tion between carotid-femoral PWV and systolic blood
pressure in both groups (patients with Chagas' disease, r =
0.38, P = 0.005; healthy subjects, r = 0.36, P = 0.043).
When patients with Chagas' disease (n = 53) were com-
pared with healthy subjects (n = 31), no differences were
found regarding the slope, linear, and angular coefficients
of the curve for both correlations between PWV and age
and PWV and SBP (all P values above 0.05), as shown in
figures 2 to 4.
Discussion
This is the first study to noninvasively assess large artery
distensibility by means of PWV analysis in Chagas' dis-
ease. We demonstrated that carotid-femoral PWV, a recog-
nized index of aortic distensibility, is not modified in
patients with Chagas' disease as compared with that in
healthy subjects. Likewise, pulse pressure was not differ-
ent among the 4 groups. These findings suggest that the
elastic properties of large arteries are not affected by Cha-
gas' disease, independently of the clinical manifestations
of the disease.
Chagas' disease, or South American trypanosomiasis, is
caused by the hemoflagellate Trypanosoma cruzi and has
different forms of clinical manifestation, including
asymptomatic or indeterminate form, electrocardio-
graphic manifestations (right bundle-branch block,
arrhythmias), gastrointestinal manifestations, and overt
clinical heart failure. The pathological involvement of the
heart in the chronic phase of Chagas disease is character-
ized by the presence of inflammatory infiltrates and focus
of myocarditis associated with focal fibrosis, with a varia-
ble intensity. Experimentally, Chagas' disease causes vas-
culitis of the large arteries, affecting the muscular and
endothelial layers [9,10]. This involvement could chroni-
cally produce modifications in the elastic properties of
large arteries. However, in our study, aortic PWV was not
different in patients with different forms of Chagas dis-
ease compared with that in healthy subjects. Although
PWV is not a direct measure of arterial distensibility, sev-
eral reports have considered it an important index of arte-
rial stiffness and consequently, arterial distensibility.
Some recognized cardiovascular risk factors could modify
differently aortic distensibility and PWV measurement.
However, the most important factors like age and blood
pressure interfere similarly with both arterial distensibility
and PWV measurement. In our study the correlations of
PWV, age, and systolic blood pressure were statistically
significant in both control and Chagas disease groups,
supporting the data indicating that the influence of both
blood pressure and age on vascular properties are not
modified in patients with Chagas' disease. So, our data
support the conclusion that aortic distensibility is not
impaired in patients with different forms of Chagas' dis-
ease, even in those with heart failure.
Our results observed in patients without CHF coincide
with those observed by Consolim-Colombo et al [12]
who demonstrated that endothelial function was pre-
served in patients with Chagas' disease without CHF.
Thus, it seems that functional properties of both small
arteries, evaluated by endothelial function in the above-
mentioned study, and large arteries, studied in our report
are not affected by Chagas' disease.
Findings in patients with heart failure have been more
contradictory, however. Arnold et al [13] showed that
patients with mild to severe CHF had a significantly
higher brachial PWV than healthy subjects had, even con-
sidering that patients with moderate to severe CHF were
on vasodilator drugs. In another study, Giannattasio et al
[14] also observed a decrease in radial artery compliance
assessed by high-resolution ultrasound in 25 patients with
CHF. On the other hand, Eliakim et al [15] and Merillon
Pulse-wave velocity values in the 4 groups Figure 1
Pulse-wave velocity values in the 4 groups.
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et al [16] did not observe any alterations in aortic PWV
invasively assessed in patients with CHF. It is possible that
such disparities may be due to differences in the severity
of CHF present in the patients studied and also to the dif-
ferent methods used to assess arterial distensibility. More
recently, Mitchell et al [17] has demonstrated that the cen-
tral pulsatile load was increased in CHF, but, in contrast,
distal (muscular) conduit vessels tended to be less stiff
Relationship between pulse-wave velocity and systolic blood pressure in Chagas' disease group as compared with that in the  control group Figure 3
Relationship between pulse-wave velocity and systolic blood pressure in Chagas' disease group as compared with that in the 
control group.
y = 0,050x + 2,370  Chagas group
y = 0,057x + 2,056  Control group
0
2
4
6
8
10
12
14
80 90 100 110 120 130 140 150
Systolic blood pressure (mmHg)
P
W
V
 
(
m
/
s
)
p > 0.05 
Relationship between pulse-wave velocity and age in Chagas' disease groups as compared with that in the control group Figure 2
Relationship between pulse-wave velocity and age in Chagas' disease groups as compared with that in the control group.
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(lower carotid radial PWV) in the same patients with CHF.
The increased functional stiffness of the central conduits
in CHF observed in Mitchell's study is not apparent in glo-
bal measures such as augmentation index or total artery
compliance, probably explained by the contrasting
changes in central and peripheral conduits. In our study,
the absence of modifications in carotid pulse-wave veloc-
ity in Chagas' disease even in the presence of mild to mod-
erate CHF, could be partially explained by the results of
Mitchell et al [17].
Three possible mechanisms may be responsible for mod-
ifications in arterial distensibility in patients with CHF:
increased plasma or tissue concentrations of a number of
vasoconstrictor substances secondary to enhanced sympa-
thetic drive; a reduction in the shear endothelium stress
and secretion of endothelial relaxing factors as a conse-
quence of a reduction in cardiac contractility and output;
and arterial wall edema and stiffness due to sodium and
water retention [18]. All these mechanisms are more
intense in patients with severe CHF, patients who were
excluded in our study so as not to interfere in a possible
effect of Chagas' disease on the PWV. Thus, as we excluded
patients with severe CHF, and also patients with ischemic
heart disease or hypertension, situations that knowingly
modify PWV, our results suggest that the presence of mild
to moderate heart failure per se in patients with Chagas'
disease does not alter the elastic properties of great arter-
ies. However, as we do not assess other vascular functional
properties like endothelial function in these patients, it is
not possible to totally exclude vascular modifications in
patients with Chagas disease and heart failure.
The lack of differences in carotid-femoral PWV between
healthy subjects and the different groups with Chagas dis-
ease could be due to type II (beta) statistical error fre-
quently observed in a study such as this involving a small
number of patients. However, we can observe that the
standard deviation of PWV measurements is very small,
and even considering a greater statistical significance
(0.10) the values remained not different among the
groups.
In both the control healthy group and patients with Cha-
gas disease, a positive and similar relationship between
PWV and age and between PWV and systolic blood pres-
sure was observed, as described previously [10]. We did
this analysis to verify whether the aging and blood pres-
sure influence on aortic distensibility could be modified
by the presence of Chagas disease. Thus, Chagas' disease
seems not to accelerate the arterial stiffening secondary to
aging or elevated blood pressure.
One limitation of our study must be addressed. For ethical
reasons, we did not withdraw diuretic and vasodilator
drugs used by patients with CHF. Therefore, it would be
possible that such drugs may have had a favorable effect
on PWV, leading to a "pseudonormalization" of a modi-
fied carotid-femoral PWV in such patients.
Relationship between pulse wave velocity and diastolic blood pressure in Chagas' disease group as compared with that in the  control group Figure 4
Relationship between pulse wave velocity and diastolic blood pressure in Chagas' disease group as compared with that in the 
control group.
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In summary, the present study indicates that carotid-fem-
oral PWV is normal in patients with Chagas' disease,
despite the presence of electrocardiographic abnormali-
ties or mild heart failure, suggesting that large artery dis-
tensibility is not primarily affected in this disease.
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